Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 952339415 | 9523394 | 15 | F | 20130128 | 20160824 | 20130913 | 20160831 | EXP | CA-ROCHE-1185966 | ROCHE | 56.10 | YR | F | Y | 72.60000 | KG | 20160831 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 952339415 | 9523394 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DAY 1 AND 15?LAST DOSE WAS RECEIVED ON 12-FEB-2013. | B62332,B60962,H0762 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||
| 952339415 | 9523394 | 2 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DAY 1 AND 15 | B62332,B60962,H0762 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||
| 952339415 | 9523394 | 3 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DAY 1 AND 15 | B62332,B60962,H0762 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | ||||||
| 952339415 | 9523394 | 4 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 103792 | SOLUTION FOR INFUSION | |||||||||
| 952339415 | 9523394 | 5 | SS | NAPROXEN. | NAPROXEN | 1 | Unknown | 17581 | |||||||||||
| 952339415 | 9523394 | 6 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Unknown | 125427 | |||||||||||
| 952339415 | 9523394 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 8 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 9 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 10 | C | PANTOLOC | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 11 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 12 | C | LYSINE | LYSINE | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 13 | C | NIACINAMIDE | NIACINAMIDE | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 14 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 15 | C | PRIMROSE | 2 | 0 | |||||||||||||
| 952339415 | 9523394 | 16 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 952339415 | 9523394 | 17 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | |||||||||
| 952339415 | 9523394 | 18 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG | |||||||||
| 952339415 | 9523394 | 19 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 952339415 | 9523394 | 20 | C | ALOE VERA JUICE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 952339415 | 9523394 | 1 | Rheumatoid arthritis |
| 952339415 | 9523394 | 4 | Product used for unknown indication |
| 952339415 | 9523394 | 5 | Product used for unknown indication |
| 952339415 | 9523394 | 6 | Product used for unknown indication |
| 952339415 | 9523394 | 16 | Premedication |
| 952339415 | 9523394 | 17 | Premedication |
| 952339415 | 9523394 | 18 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 952339415 | 9523394 | OT |
| 952339415 | 9523394 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 952339415 | 9523394 | Arthralgia | |
| 952339415 | 9523394 | Asthenia | |
| 952339415 | 9523394 | Breast cancer | |
| 952339415 | 9523394 | Breast cancer metastatic | |
| 952339415 | 9523394 | Breast cancer recurrent | |
| 952339415 | 9523394 | Breast mass | |
| 952339415 | 9523394 | Dehydration | |
| 952339415 | 9523394 | Diarrhoea | |
| 952339415 | 9523394 | Epistaxis | |
| 952339415 | 9523394 | Fatigue | |
| 952339415 | 9523394 | Gastrointestinal inflammation | |
| 952339415 | 9523394 | Hypotension | |
| 952339415 | 9523394 | Influenza | |
| 952339415 | 9523394 | Infusion related reaction | |
| 952339415 | 9523394 | Joint swelling | |
| 952339415 | 9523394 | Nausea | |
| 952339415 | 9523394 | Neuropathy peripheral | |
| 952339415 | 9523394 | Osteoarthritis | |
| 952339415 | 9523394 | Paranasal sinus discomfort | |
| 952339415 | 9523394 | Throat irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 952339415 | 9523394 | 1 | 20130128 | 20130212 | 0 | |
| 952339415 | 9523394 | 2 | 20141218 | 0 | ||
| 952339415 | 9523394 | 3 | 20140619 | 0 | ||
| 952339415 | 9523394 | 6 | 20160823 | 0 | ||
| 952339415 | 9523394 | 16 | 20130128 | 0 | ||
| 952339415 | 9523394 | 17 | 20130128 | 0 | ||
| 952339415 | 9523394 | 18 | 20130128 | 0 |